Why California Construction Employers Can Still Drug Test for Marijuana While Others Can’t
California’s AB 2188 protects workers from marijuana discrimination, yet construction employers can still test and fire. The exemption reveals workplace safety’s complex reality.
Trump Eyes Lower-Risk Label for Marijuana, Defying Long-Standing Federal Drug Stance
Trump’s potential marijuana reclassification from Schedule I to III faces fierce internal resistance while promising to revolutionize cannabis banking and research access.
Petition Power vs. Policing: Marijuana Legalization Debate Grows in Oklahoma
Oklahoma’s medical marijuana boom sparked international crime rings and tripled youth usage rates. Can petition power overcome these alarming policing realities?
Thinking of Starting a Cannabis Grow? Here’s What Most New Operators Get Wrong
Most cannabis entrepreneurs burn through millions before realizing these critical mistakes that destroy 80% of new operations before they turn profitable.
DEA’s 2024 Cannabis Crackdown: Over Five Million Plants Seized, Thousands Arrested Amid Legalization Wave
Despite state legalization sweeping America, DEA agents seized 5.3 million cannabis plants and made thousands of arrests in 2024. Federal crackdowns intensify unexpectedly.
Federal Study Shows Cannabis Outperforms Traditional Meds for IBD Symptom Relief
Federal research reveals 63% of IBD patients find cannabis more effective than traditional medications, with 20% reducing opioid dependence. The results challenge conventional treatment approaches.
Single Dose of Psilocybin Triggers Surprising, Lasting OCD Relief Within Hours, Study Reports
Single psilocybin dose eliminates severe OCD symptoms within hours—defying decades of treatment protocols that require months to show minimal progress.
